Risk factors revealed for anti-tuberculosis drug hepatotoxicity

The risk for hepatotoxicity among patients treated with anti-tuberculosis (TB) drugs is affected by gender, ethnicity, and the presence of genetic polymorphisms, say Argentinean researchers.